Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Ejhaem|April 6, 2021
Is sickle cell disease a risk factor for severe COVID-19 outcomes in hospitalized patients? A multicenter national retrospective cohort studyAbdulkarim Abdulrahman, Mohammed Wael, Fajer AlAmmadi, et al.Tropical Diseases, Travel Medicine and Vaccines|January 13, 2021
Quarantining arriving travelers in the era of COVID-19: balancing the risk and benefits a learning experience from BahrainAbdulkarim Abdulrahman, Manaf AlSabbagh, Abdulla AlAwadhi, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 1, 2021
The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19Marwa Ali Almadhi, Abdulkarim Abdulrahman, Sayed Ali Sharaf, et al.Journal of the Saudi Heart Association|November 30, 2022
The Impact of a New STEMI Hotline on Cardiovascular Outcomes in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: A National Cohort StudyFawaz Bardooli, Ali Alhashli, Omar Y AlKhaja, et al.The British Journal of Ophthalmology|January 16, 2021
OCT-angiography detects longitudinal microvascular changes in glaucoma: a systematic reviewAna Miguel, André Silva, Joao Barbosa-Breda, et al.Heart Views : the Official Journal of the Gulf Heart Association|December 8, 2022
Real-World Experience with a 60-mm-Long Stent in the Setting of Primary Percutaneous Coronary InterventionBabu Thevan, Abdulkarim Abdulrahman, Suddharsan Subbramaniyam, et al.Infectious Diseases and Therapy|January 23, 2021
The Efficacy and Safety of Hydroxychloroquine in Patients with COVID-19: A Multicenter National Retrospective CohortAbdulkarim Abdulrahman, Islam AlSayed, Marwa AlMadhi, et al.Scientific Reports|May 12, 2021
Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 diseaseManaf AlQahtani, Abdulkarim Abdulrahman, Abdulrahman Almadani, et al.Scientific Reports|March 24, 2022
Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 diseaseManaf AlQahtani, Nitya Kumar, Dhuha Aljawder, et al.BMC Infectious Diseases|November 21, 2021
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trialsCathrine Axfors, Perrine Janiaud, Andreas M Schmitt, et al.Pageof 2